BioCentury
ARTICLE | Clinical News

Flublok: Phase III data

February 10, 2014 8:00 AM UTC

An open-label, Japanese Phase III trial in 55 healthy volunteers aged >=61 years showed that intramuscular ASP7374 had "favorable immunogenicity." Astellas and partner UMN could not be reached for det...